rs28730295

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS1

The NM_000660.7(TGFB1):​c.860+2797T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00129 in 150,646 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.0013 ( 0 hom., cov: 30)

Consequence

TGFB1
NM_000660.7 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.187

Publications

0 publications found
Variant links:
Genes affected
TGFB1 (HGNC:11766): (transforming growth factor beta 1) This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate a latency-associated peptide (LAP) and a mature peptide, and is found in either a latent form composed of a mature peptide homodimer, a LAP homodimer, and a latent TGF-beta binding protein, or in an active form consisting solely of the mature peptide homodimer. The mature peptide may also form heterodimers with other TGFB family members. This encoded protein regulates cell proliferation, differentiation and growth, and can modulate expression and activation of other growth factors including interferon gamma and tumor necrosis factor alpha. This gene is frequently upregulated in tumor cells, and mutations in this gene result in Camurati-Engelmann disease. [provided by RefSeq, Aug 2016]
TGFB1 Gene-Disease associations (from GenCC):
  • Camurati-Engelmann disease
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • inflammatory bowel disease, immunodeficiency, and encephalopathy
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • cystic fibrosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00129 (194/150646) while in subpopulation AFR AF = 0.00451 (185/41018). AF 95% confidence interval is 0.00398. There are 0 homozygotes in GnomAd4. There are 102 alleles in the male GnomAd4 subpopulation. Median coverage is 30. This position passed quality control check.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TGFB1NM_000660.7 linkc.860+2797T>G intron_variant Intron 5 of 6 ENST00000221930.6 NP_000651.3 P01137A0A499FJK2
TGFB1XM_011527242.3 linkc.863+2797T>G intron_variant Intron 5 of 6 XP_011525544.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TGFB1ENST00000221930.6 linkc.860+2797T>G intron_variant Intron 5 of 6 1 NM_000660.7 ENSP00000221930.4 A0A499FJK2
TGFB1ENST00000600196.2 linkc.712+3084T>G intron_variant Intron 4 of 5 5 ENSP00000504008.1 A0A7I2YQL8
TGFB1ENST00000677934.1 linkc.634+5661T>G intron_variant Intron 3 of 4 ENSP00000504769.1 A0A7I2V5Z9
TGFB1ENST00000598758.5 linkn.148+2797T>G intron_variant Intron 1 of 3 5

Frequencies

GnomAD3 genomes
AF:
0.00127
AC:
192
AN:
150610
Hom.:
0
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.00447
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000465
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000971
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.00129
AC:
194
AN:
150646
Hom.:
0
Cov.:
30
AF XY:
0.00139
AC XY:
102
AN XY:
73348
show subpopulations
African (AFR)
AF:
0.00451
AC:
185
AN:
41018
American (AMR)
AF:
0.000464
AC:
7
AN:
15070
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5136
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4760
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10046
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
280
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
67874
Other (OTH)
AF:
0.000962
AC:
2
AN:
2080
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.517
Heterozygous variant carriers
0
12
24
35
47
59
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00133
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
6.3
DANN
Benign
0.33
PhyloP100
0.19

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs28730295; hg19: chr19-41844991; API